BUY Divi's Laboratories LimitedSwati Hotkar, Nirmal Bang Securities

bySwati Hotkar, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via Zee Business (Live)

Entry₹8,548Inferred
Target₹8,800
Total upside +2.95% (call closed)
Stop loss₹8,280-3.14% risk
At expiry₹8,49624 Aug 2026, 3:30 pm
Expired-0.61%auction close

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Aug 2026
6 supporting4 neutral1 opposing
Supports the BUY call (6)

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·19 Aug · 4d ago

(opens in new tab)

4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·20 Aug · 4d ago

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·18 Aug · 6d ago

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·6 Aug · 3w ago

(opens in new tab)

Divi's Labs Q1 Results: Profit Jumps 65.5%, Revenue Up 28% - Key Numbers

NewsNdtv-Profit·1 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.